Nuwellis (NUWE) vs Valion Bio (VBIO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Nuwellis is the larger company by market cap ($2.5 million vs $1.9 million), about 1.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | NUWE | VBIO |
|---|---|---|
| Share price | $0.6907 | $2.19 |
| Market cap | $2.52M | $1.94M |
| 1-day change | -1.48% | -7.98% |
| P/E ratio (TTM) | 0.00 | — |
| EPS (TTM) | $435.92 | $-161.21 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $172.90 | $78.75 |
| 52-week low | $0.6753 | $2.05 |
| Distance from 52-week high | -99.60% | -97.22% |
| Average volume | 4.33M | 1.46M |
| Shares outstanding | 3.65M | 887.59K |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
NUWE vs VBIO FAQ
Which is bigger, Nuwellis or Valion Bio?
Nuwellis (NUWE) is larger, with a market capitalization of $2.52M compared with $1.94M for Valion Bio (VBIO).
Are Nuwellis and Valion Bio in the same industry?
Yes. Both are classified in the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry within the Health Care sector.